Myrurgia Abdul Hamid

Papers

Total Citations

H-Index

About

Dr. Myrurgia Abdul Hamid is a leading expert in the surgical management of thymic disorders, with a focused research portfolio bridging thoracic oncology and neurology. Her work centers on the intersection of thymoma treatment and myasthenia gravis, a neuromuscular autoimmune disease. Dr. Hamid’s major contributions include pioneering the use of robotic-assisted thymectomy (RATS) for thymomas, as demonstrated in her landmark 2021 retrospective study of Dutch patients, which established long-term oncologic and neurologic outcomes for this minimally invasive approach. Her research has been instrumental in characterizing subclinical myasthenia gravis in thymoma patients, a critical finding that has reshaped preoperative screening protocols. With her most-cited paper garnering 18 citations, Dr. Hamid’s work has directly influenced clinical guidelines in the Netherlands, where her institution is a designated center of excellence. Her 2023 comparative study further refined surgical indications by analyzing outcomes in acetylcholine-receptor-antibody-positive patients, providing evidence that robotic thymectomy offers superior results for both thymomatous and nonthymomatous cases. Dr. Hamid’s research continues to advance personalized surgical strategies for complex thymic pathologies.